Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHINY: Conbercept for Myopic CNV
NCT01809223Phase 3Unknown
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Aug 2012
- Primary completion
- Feb 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of conbercept in Myopic Choroidal Neovascularization (mCNV), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
conbercept
03
Conditions
Myopic Choroidal Neovascularization (mCNV)
Beyond the preview
Go deeper on NCT01809223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809223.